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Abstract
Sudden cardiac death (SCD) in an athlete is a rare but tragic event. In view of this, pre-
participation cardiac screening is mandatory across many sporting disciplines to identify 
those athletes at risk. Echocardiography is a primary investigation utilized in the pre-
participation setting and in 2013 the British Society of Echocardiography and Cardiac 
Risk in the Young produced a joint policy document providing guidance on the role 
of echocardiography in this setting. Recent developments in our understanding of the 
athlete’s heart and the application of echocardiography have prompted this 2018 update.
Introduction
Update to 2013 guidelines
The first British Society of Echocardiography (BSE) 
and Cardiac Risk in the Young (CRY) guidelines for the 
role of echocardiography in the cardiac screening of 
sports participants were published in 2013 and have 
been implemented in screening of athletes throughout 
the United Kingdom. Since its release there have been 
important additions to the evidence base, which have 
advanced our understanding of the athlete’s heart (AH) 
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and the role of diagnostic testing. This includes new 
international guidelines on the athlete’s electrocardiogram 
(ECG) (1) and further insight into the multi-factorial 
nature of the phenotypic expression of the AH (2, 3). 
Consequently, the BSE and CRY consider it timely to 
provide an updated version of the 2013 guidelines.
Which conditions to look out for?
This BSE document is aimed at providing guidance for the 
use of echocardiography in screening young athletes (ages 
14–35 years) for inherited and congenital cardiac disease 
and is endorsed by CRY. Sudden cardiac death (SCD) in 
young athletes although relatively rare has a devastating 
impact on the individual, their family and the wider 
community. The causes of SCD in the athletic population 
have been reported extensively in the literature with 
Fig. 1 highlighting relevant conditions from a UK registry 
of young athletes (4). Although in contemporary studies 
sudden arrhythmic death syndrome (SADS) predominates, 
structural heart disease, potentially detectable by 
echocardiography, still comprise many SCD cases in young 
and athletic individuals (5, 6). Cardiac screening is aimed 
at identifying these conditions to reduce the risk of SCD.
The 12-lead electrocardiogram should be the 
first investigation
Current European recommendations (7) for cardiac 
screening of the athlete state that following a detailed 
questionnaire (including any symptoms or family history) 
and brief examination, the 12-lead electrocardiogram 
(ECG) should be the primary investigation. The ECG 
should be interpreted in accordance with International 
Consensus guidelines (1) (Fig. 2). Those with 2 or more 
‘Borderline ECG Findings’ or ANY ‘Abnormal ECG 
Findings’ require further investigation.
A full standard echocardiographic assessment 
should be performed
The specific sporting/screening organisation will decide 
whether their athletes require a routine transthoracic 
echocardiogram (TTE) as a first-line investigation 
within the standard screening process. In the case of an 
ECG-only screening, TTE is recommended as a second-line 
investigation in those athletes with an abnormal ECG, 
cardiovascular symptoms, abnormal physical examination 
findings or a family history of sudden death under the age 
of 40 years. Regardless of whether TTE is a first- or second-
line investigation, it should be performed according to 
the BSE Minimum Dataset for a Standard Transthoracic 
Echocardiogram in an Adult (8) and should also consider 
recommendations made in the Supplementary Protocols 
for (i) Comprehensive Assessment of the Right Heart and 
(ii) the Assessment of Diastolic Function. Details of where 
and how to measure specific echo parameters are given in 
these three protocols, which are available online at www.
bsecho.org. There are however additional elements that 
may be considered optional in non-athletes that become 
highly relevant in athletes to ensure a comprehensive 
evaluation. For example, the assessment of the coronary 
arteries to exclude coronary artery anomalies. If there 
is evidence of an abnormality, other supplementary 
guidelines may then become relevant and should be 
utilized. For example, the application of this protocol may 
identify right ventricular (RV) enlargement and possible 
dysfunction, and it would therefore be pertinent to then 
utilize the ARVC protocol to obtain further diagnostic 
information.
Type of athletic activity should be known
It is important to use the BSE normative values based 
on sex and age but take account of the type of sporting 
activity performed. All echocardiographers involved 
in cardiac screening of athletes should understand the 
physiological adaptation in cardiac structure and function 
to regular exercise, which can be variable depending 
on the type and volume of exercise training. All cardiac 
chambers may enlarge (9). Physiological adaptation of 
the left ventricle usually falls within the constraints of 
Figure 1
Causes of sudden cardiac death.
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normal geometry although eccentric hypertrophy may 
occur especially in athletes who engage in high dynamic 
sports (10). A relatively recent systematic review and meta-
analysis (9) highlights ranges for trained male athletes 
and demonstrates that greater LV chamber size is likely 
in endurance athletes compared to those that have a 
resistance focus. Resistance activity can be defined as 
Figure 2
ECG athlete interpretation.
Table 1 Sporting examples demonstrating specific MET 
values for determining exercise intensity (12).
Sporting discipline Metabolic equivalent (MET)
Soccer 10.0
Running (6 mph) 10.0
Running (7.5 mph) 12.5
Running (10.9 mph) 18.0
Cycling (>20 mph) racing 16.0
Cycling (<10 mph) leisure 4.0
Cricket 5.0
Rugby 10.0
Tennis (singles) 8.0
Hockey 8.0
Boxing 12.0
Golf 4.5
Rowing (competitive) 12.0
Swimming (leisure) 6.0
Swimming (competitive) 10.0
Figure 3
Pre-echocardiographic information.
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anaerobic isometric exercise at incremental workloads 
of >30% maximal voluntary contraction and includes 
sporting disciplines such as martial arts, wind-surfing 
and weight-lifting. Endurance activity can be defined 
as aerobic isotonic dynamic exercise at incremental 
workloads of 70–90% of maximum heart rate and includes 
sporting disciplines such as long and middle distance 
running, swimming or cycling, soccer and basketball. It is 
important to note that many sporting disciplines involve 
a combination of resistance and endurance exercise 
(boxing, rugby, rowing, American football) and therefore 
there is likely to be an overlap in ranges. The Mitchells 
classification provides information on specific sporting 
disciplines relative to the static and dynamic components 
and may serve as a useful guide in this regard (11).
Amount of athletic activity should be known
When screening patients for inherited 
cardiac disease due to a family history, 
the referring physician/echocardiographer 
should establish the patient’s level of physical activity. 
The total volume of training can be defined as 
(volume = intensity × duration) or Metabolic Equivalent 
Test (MET-h/week = METS × duration). An example of 
a select range of sporting disciplines and their specific 
METS is highlighted in Table  1. In summary, low-
intensity exercise is defined as corresponding to 1.8–2.9 
METS, moderate intensity is defined as corresponding 
to 3–6 METS and high-intensity exercise is defined 
as >6 METS.
Table 2 Considerations for each of the specific pre-examination factors.
Sex 
 
 
Cardiac chamber dimensions in female athletes rarely fall outside of the established ‘normal range’. If 
they do, further investigation is required (10, 13, 14, 15)
It is more common for male athletes to demonstrate a degree of eccentric remodeling of all cardiac 
chambers (10, 15)
Age Highly trained junior athletes still develop cardiac remodeling in response to physiological conditioning, 
but this is often at a lower magnitude than in senior athletes (16, 17)
That aside, where structural values fall outside the BSE ‘normal range’ functional assessment is key
Ethnicity LV (18) and RV (19) cavity sizes are similar between African/Afro-Carribean and white athletes; however, 
wall thicknesses and LA size are often larger in the African/Afro-Carribean athlete (19, 20)
Any wall thickness measurement with a value greater than 13 mm in white male athletes (or greater 
than 11 mm in white female athletes) or greater than 15 mm (20) in African/Afro-Carribean male 
athletes (or 13 mm (21) in African/Afro-Carribean female) requires further investigation
There is a lack of data pertaining to the structure and function of Asian athletes although there is no 
significant difference in ECG findings between West Asian and Caucasian athletes (22). The lack of 
available data on Asian ethnicity suggests that standard criteria as applied to Caucasian athletes 
should be utilized until further data is avialable
Body surface area (BSA) 
 
 
The relationship between body size and chamber dimensions is well established (23, 24) and therefore 
all chamber dimensions should be indexed for body surface area. That aside, cardiac adaptation to 
exercise involves eccentric hypertrophy beyond what may be attributable to body composition alone 
(9, 23)
In the extremes of height and weight (BSA > 2.3 m2) non-indexed LV wall thickness and diastolic 
diameter should not exceed 15 mm and 65 mm respectively (25)
Symptoms 
 
 
 
 
A positive history including exertional chest pain, syncope or near-syncope, irregular heartbeat or 
palpitations, shortness of breath or fatigue and in particular exertional symptoms should direct the 
echocardiographer to closely assess for potential causes of SCD (4) (Fig. 1). Symptoms are non-specific 
and therefore it is important to ensure all possible causes are excluded. That aside it is important to be 
aware that exertional chest pain may direct further evaluation for coronary anomalies while syncope 
may be related to arrhythmogenic substrate such as ARVC or HCM or to outflow obstruction
ECG changes 
 
 
The type of ECG changes that are present on an athlete’s ECG will further guide the focus of the 
examination. For example T-wave inversion in leads V1–V3 is one of the hallmarks of ARVC and should 
lead to a more focused assessment of the right heart (26). On the contrary inferolateral T-wave 
inversion is more frequently present in HCM and should prompt a detailed LV assessment (1)
Training volume/level Elite athletes are likely to demonstrate a greater degree of physiological cardiac adaptation than those 
athletes who train at a much lower intensity (27)
Sporting type 
 
 
It is apparent that specific sporting disciplines create a specific stimulus that directs the degree of 
chamber enlargement (28, 29). Endurance athletes (cyclists, rowers, long distance runners) are likely to 
have a greater adapatation of all chambers than athletes who engage in sport of a combined stimulus 
(soccer, tennis, hockey) or strength (powerlifting, wrestling, judo) (9, 23, 30, 31, 32)
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Table 3  Additional image acquisition.
View and modality Explanatory note Image
PSAX AV level (2D) (1) Identify coronary ostia. The left and right ostia 
usually originate from their respective aortic sinuses
(2) Ensure origin is at sinus level
(3) Identify proximal courses and exclude aberrant 
vessel, especially malignant course between great 
vessels (aorta and pulmonary artery) (33)
PSAX BASAL LV 
level (2D)
LV wall thicknesses should be measured from the 
maximum dimension at end diastole from:
(1) Anterior septum
(2) Inferior septum
(3) Posterior/Inferolateral wall
(4) Lateral/Anterolateral wall
PSAX MID  
LV level (2D)
LV wall thicknesses should be measured from the 
maximum dimension at end diastole from:
(1) Anterior septum
(2) Inferior septum
(3) Posterior/Inferolateral wall
(4) Lateral/Anterolateral wall
PSAX MID to 
apical level (2D) 
 
 
 
 
 
 
 
 
 
 
 
 
 
(1) Excess LV trabeculations is a common finding in 
athletes (34)
(2) LV hypertrabeculation is more prevalent in black 
athletes
(3) Red-flags – thinned compacted layer <5 mm and 
regional wall motion abnormality in the region of 
excess trabeculation. Further imaging is advised to 
exclude Left Ventricular Non-Compaction (LVNC) 
Cardiomyopathy 
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Echocardiographic examination
Pre-echocardiographic information
The aim of the TTE is to differentiate physiological 
adaptation from pathological abnormality where possible. 
Therefore, it is important that the echocardiographer 
understands the main pathological conditions that may be 
found and must be aware of normal variation in response 
to exercise. The extent and nature of physiological cardiac 
adaptation in the AH is based on several factors and an 
attempt should be made to obtain information on each 
of these before the TTE is performed. This should include 
the list of information presented in Fig.  3. Although 
a standard minimum dataset is recommended for all 
echocardiograms, prior knowledge of these demographics 
and ECG findings will help to focus the examination, 
aid interpretation of findings and contribute to the 
subsequent management of the athlete (Table 2).
Echocardiographic examination
The following protocols should be strictly adhered to so as 
to exclude pathology:
 • BSE Minimum Dataset.
 • BSE protocol for the assessment of LV diastolic function.
 • BSE protocol on the assessment of the right heart with 
a focus on ARVC.
 • BSE protocol for HCM.
 • BSE protocol for DCM.
In addition, the following image acquisition should be 
made (Table 3).
LV geometry should be determined using a combination 
of LV mass indexed to BSA (LVMI) and relative wall thickness 
(RWT) (35). LVMI is calculated as per BSE guidelines (5) 
and RWT is calculated by summating septal and posterior 
wall thickness in diastole and dividing into the LV diastolic 
cavity dimension. LV geometry can be reported as ‘normal’ 
(normal RWT and normal LVMI), ‘concentric remodeling’ 
(increased RWT with normal LVMI), ‘concentric 
hypertrophy’ (increased RWT and increased LVMI) or 
‘eccentric hypertrophy’ (normal RWT with increased LVMI) 
according to published criteria (Fig. 4).
These new guidelines raise the potential diagnostic 
role of exercise testing in the athlete who presents 
with borderline to reduced ventricular systolic and/or 
diastolic function. The physiological mechanisms for 
this are based upon the enlarged chamber requiring 
minimal contractility to maintain an adequate stroke 
volume at rest. During exercise, the AH can generate a 
much greater reserve than in the non-athlete and allows 
for the increased stroke volumes that are required for 
optimal cardiac output. This is demonstrated by an 
increase in contractility and early diastolic filling as 
determined by EF, TDI and Doppler (trans-mitral E wave, 
trans-mitral A wave, LVOT VTI, Septal S′, E′ and A′ and 
Lateral S′, E′ and A′). A similar finding can be seen in the 
RV. In patients with DCM, the diseased myocardium is 
unable to generate sufficient reserve and contractility in 
response to an exercise stimulus, and contractility and 
filling do not improve or even deteriorate.
The type of exercise stimulus has not been clearly 
defined. A short isometric exercise e.g. sit ups or squats 
or a supine cycle ergometer causing an increase of 50% 
in heart rate may aid to differentiate AH from DCM. 
Unpublished data suggest that an increase of >11% in 
ejection fraction is a normal response in the athlete. 
There are less data available on RV response to exercise 
but anecdotal evidence would suggest a similar pattern 
to that of the LV i.e. increased RVFAC and TDI in athletes 
and a blunted response in those with pathological 
adaptation.
Figure 4
Defining LV geometry.
Table 4 Upper limits for LV and RV.
Parameter Male athlete Female athlete
LV dimension diastole (mm) 64 57
LV interventricular septal 
thickness (mm)
13 11
LV posterior wall thickness (mm) 13 11
LV mass (g) 263 243
RVOT1 (mm) 44
RVOT2 (mm) 41
RVD1 (mm) 49
RVD2 (mm) 44
RVD3 (mm) 92  
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Data interpretation
Due to the multi-factorial nature of the AH, it is difficult 
to provide an all-encompassing normal range. Data from 
key studies and meta-analyses for LV size and function in 
female and male athletes respectively (9, 10, 13, 36) have 
been included (Table 4). Table 4 also provides non-gender 
specific cut-offs for RV structure obtained from three 
large studies (19, 23, 30). It is important to acknowledge 
that body size directly influences cardiac size and in the 
extremes of body size, values above the proposed upper 
limits may be observed (20). In view of this, the data 
in both the tables and the diagnostic algorithms should 
only be used to guide subsequent assessment rather than 
providing definitive diagnostic information.
The following algorithms highlight possible 
interpretation of the athlete’s echocardiogram in the 
absence of normal LV or RV geometry (Figs 5 and 6). 
Definitions of concentric and eccentric hypertrophy 
have been generated based on the use of LVMI and 
RWT and/or absolute non-indexed cavity size or wall 
thickness. The cavity cut-off for subsequent use of 
the algorithm has been based on non-athletes as a 
safety net to reduce the risk of false-negative results. 
In addition, a reporting template for pre-participation 
screening is provided in Supplementary Fig.  1 
AH Athletic heart
ARVC Arrhythmogenic right ventricular cardiomyopathy
AV Aortic valve
BSA Body surface area
DCM Dilated cardiomyopathy
EDV End diastolic volume
EF Ejection fraction
HCM Hypertrophic cardiomyopathy
IVSd Interventricular septal (thickness) in diastole
LA Left atrium
LBBB Left bundle branch block
LV Left ventricle
LVDd Left ventricular diameter in diastole
LVH Left ventricular hypertrophy
LVMI Left ventricular mass index
LVNC Left ventricular non-compaction
LVPWd Left ventricular posterior wall (thickness) in diastole
MET Metabolic equivalent test
PSAX Parasternal short axis
RA Right atrium
RBBB Right bundle branch block
RV Right ventricle
RVD Right ventricular diameter
RVOT Right ventricular outflow tract
RWT Relative wall thickness
SADS Sudden arrhythmic death syndrome
SV Stroke volume
TDI Tissue Doppler imaging
TTE Transthoracic echocardiography
Abbreviations
Figure 5
Algorithm when left-sided parameters suggest abnormal geometry.
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(see section on supplementary data given at the end of 
this article).
Definitions
Eccentric hypertrophy: cardiac chamber response to 
increased preload manifesting as a larger cavity and 
a proportional increase in wall thickness to offset an 
elevated wall stress. The quantitative values to define 
eccentric hypertrophy are presented in Fig. 4.
Concentric hypertrophy/remodeling: cardiac chamber 
response to increased afterload manifesting as an increase 
in wall thickness (of any walls) without a concomitant 
increase in cavity dimension. The quantitative values to 
define concentric hypertrophy and remodeling are also 
presented in Fig. 4.
Sudden arrhythmic death syndrome: SCD with structurally 
normal heart on post-mortem, with no abnormality 
identified on macroscopic and histological evaluation and 
negative toxicology screening.
Idiopathic left ventricular hypertrophy: cardiomyocyte 
hypertrophy with or without fibrosis in the absence of 
myocyte disarray.
Idiopathic left ventricular fibrosis: isolated myocardial 
fibrosis.
Supplementary data
This is linked to the online version of the paper at https://doi.org/10.1530/
ERP-17-0075.
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